CairnsAPDuncanMKHinderAETaggartAJ. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis. Ann Rheum Dis2002; 61: 1031–1032.
3.
ViaCSShustovARusVLangTNguyenPFinkelmanFD. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J Immunol2001; 167: 6821–6826.
4.
YungRPowersDJohnsonK. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest1996; 97: 2866–2871.
5.
ExarchouSAVoulgariPVMarkatseliTEZiogaADrososAA. Immune‐mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol2009; 38: 328–331.
SpillaneAPXiaYSniezekPJ. Drug-induced lupus erythematosus in a patient treated with adalumimab. J Am Acad Dermatol2007; 56: S114–S116.
9.
ExarchouSAVoulgariPVMarkatseliTEZiogaADrososAA. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol2009; 38: 328–331.
10.
ChogleARShahCVMurthyAK. Role of anti-tumor necrosis factor-alpha blockers in inducing lupus erythematosus tumidus in ‘rhupus syndrome’. J Rheumatol2011; 38: 1218–1219.
